Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3298

Actual shortage: 230 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 9 (0%)
Resolved: 3056 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

28 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TADALAFIL PAH 20MG TABLET Resolved 2020-07-24 2021-01-19 121090
APO-TADALAFIL PAH 20MG TABLET Resolved 2022-02-18 2022-04-18 155321
APO-TADALAFIL PAH 20MG TABLET Resolved 2023-11-24 2023-12-22 211478
APO-TADALAFIL PAH 20MG TABLET Resolved 2024-04-19 2024-05-03 225785
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2019-08-21 2019-12-07 92035
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2020-02-05 2020-03-11 105359
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2023-05-26 2023-06-02 193209
APO-TAMOX TAB 10MG 10MG TABLET Resolved 2024-05-24 2024-07-19 228777
APO-TAMOX TAB 20MG 20MG TABLET Resolved 2017-09-04 2017-11-27 20909
APO-TAMOX TAB 20MG 20MG TABLET Resolved 2019-05-15 2019-12-09 84154
APO-TAMOX TAB 20MG 20MG TABLET Resolved 2024-04-12 2024-05-24 224990
APO-TAMOX TAB 20MG 20MG TABLET Resolved 2024-06-13 2024-07-19 230480
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-05-10 2017-05-13 9946
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-17 2017-10-24 15995
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-26 2017-11-13 17331
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-15 2019-02-21 72363
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619

Showing 2881 to 2900 of 3298

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-09-07 2018-09-15 60435
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2019-01-02 2019-01-02 70787
APO-FUROSEMIDE 20MG TABLET Discontinued 2018-09-07 2018-09-15 60506
APO-FUROSEMIDE 40MG TABLET Discontinued 2018-09-07 2018-09-15 60509
APO-FUROSEMIDE 80MG TABLET Discontinued 2017-03-30 2018-02-05 4719
APO GLYBURIDE TAB 2.5MG 2.5MG TABLET Discontinued 2018-09-07 2019-07-04 60515
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-HYDROCHLOROTHIAZIDE 50MG TABLET Discontinued 2018-09-07 2019-02-13 60521
APO-IBUPROFEN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60527
APO-IBUPROFEN 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793
APO-IBUPROFEN 400MG TABLET Discontinued 2018-09-07 2018-09-15 60530
APO-IBUPROFEN 400MG TABLET Discontinued 2019-01-02 2019-01-02 70799
APO-METOPROLOL (TYPE L) 50MG TABLET Discontinued 2018-09-07 2019-02-02 60634
APO-METOPROLOL 50MG TABLET Discontinued 2018-09-07 2019-01-09 60631
APO NAPROXEN TAB 125MG 125MG TABLET Discontinued 2018-09-08 2019-08-08 60663
APO-NAPROXEN 250MG TABLET Discontinued 2017-03-30 2018-02-05 4734
APO-OXAZEPAM 10MG TABLET Discontinued 2018-09-08 2019-08-30 60675
APO-OXAZEPAM 15MG TABLET To be discontinued 2018-09-08 2018-09-08 60678
APO-OXAZEPAM 30MG TABLET Discontinued 2018-09-08 2019-06-12 60681

Showing 21 to 40 of 359